Literature DB >> 32095855

Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.

Chetana Lim1, Claire Goumard1, Margarida Casellas-Robert2, Santiago Lopez-Ben2, Laura Lladó3, Juli Busquets3, Chady Salloum4, Maria Teresa Albiol-Quer2, Ernest Castro-Gutiérrez2, Olivier Rosmorduc1, Cyrille Feray4, Emilio Ramos3, Joan Figueras2, Olivier Scatton1, Daniel Azoulay5,6,7.   

Abstract

BACKGROUND: The outcomes of liver resection (LR) with a narrow margin in patients with transplantable hepatocellular carcinoma (HCC) have not been studied. The aim was to assess whether narrow margin following up-front LR impacts the incidence, timing, pattern, and transplantability of tumor recurrence in patients with initially transplantable HCC.
METHODS: All initially transplantable HCC patients undergoing hepatectomy with either narrow (<10 mm) or wide (≥10 mm) margins from 2007 to 2016 at four Western university centers were compared in terms of recurrence, transplantability of recurrence, recurrence-free survival (RFS), and intention-to-treat overall survival (ITT-OS). Independent predictors of non-transplantability of recurrence were assessed.
RESULTS: This study included 187 patients (narrow group, n = 107 vs. wide group, n = 80). Recurrence was significantly more frequent in the narrow margin group (44% vs. 26%; p = 0.01) with a shorter RFS (p = 0.03). The transplantability of recurrence and ITT-OS were, however, not different between the two groups. The presence of satellite nodules on the resected specimens emerged as the sole independent predictor of non-transplantability of tumor recurrence. The stratification of the analysis according to the presence of cirrhosis achieved essentially the same results as in the whole study population.
CONCLUSIONS: Narrow margin was associated with a higher tumor recurrence rate and a shorter RFS for patients with initially transplantable HCC. However, transplantability of recurrence and long-term ITT-OS were not impaired.

Entities:  

Mesh:

Year:  2020        PMID: 32095855     DOI: 10.1007/s00268-020-05424-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

Authors:  Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger
Journal:  Ann Intern Med       Date:  2007-10-16       Impact factor: 25.391

2.  Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.

Authors:  David Fuks; Safi Dokmak; Valérie Paradis; Momar Diouf; François Durand; Jacques Belghiti
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

3.  A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion.

Authors:  Pinghua Yang; Anfeng Si; Jue Yang; Zhangjun Cheng; Kui Wang; Jun Li; Yong Xia; Baohua Zhang; Timothy M Pawlik; Wan Yee Lau; Feng Shen
Journal:  Surgery       Date:  2018-12-13       Impact factor: 3.982

4.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal.

Authors:  R T Poon; S T Fan; I O Ng; J Wong
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

5.  Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.

Authors:  Ming Shi; Rong-Ping Guo; Xiao-Jun Lin; Ya-Qi Zhang; Min-Shan Chen; Chang-Qing Zhang; Wan Yee Lau; Jin-Qing Li
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

6.  Short-term outcomes following hepatectomy for hepatocellular carcinoma within and beyond the BCLC guidelines: A prospective study.

Authors:  Chetana Lim; Chady Salloum; Michael Osseis; Eylon Lahat; Concepción Gómez-Gavara; Philippe Compagnon; Alain Luciani; Cyrille Feray; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2017-09-19       Impact factor: 3.647

7.  Role of the width of the surgical margin in a hepatectomy for small hepatocellular carcinomas eligible for percutaneous local ablative therapy.

Authors:  Kazuaki Shimada; Yoshihiro Sakamoto; Minoru Esaki; Tomoo Kosuge
Journal:  Am J Surg       Date:  2008-04-28       Impact factor: 2.565

8.  Clinical significance of macroscopic no-margin hepatectomy for hepatocellular carcinoma.

Authors:  Seiji Oguro; Jiro Yoshimoto; Hiroshi Imamura; Yoichi Ishizaki; Seiji Kawasaki
Journal:  HPB (Oxford)       Date:  2018-04-24       Impact factor: 3.647

9.  Prognostic impact of surgical margin in patients with hepatocellular carcinoma: A meta-analysis.

Authors:  Fu-Ping Zhong; Yu-Jun Zhang; Ying Liu; Shu-Bing Zou
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  1 in total

Review 1.  Oncological outcomes of anatomic versus non-anatomic resections for small hepatocellular carcinoma: systematic review and meta-analysis of propensity-score matched studies.

Authors:  Xiao-Ming Dai; Zhi-Qiang Xiang; Qian Wang; Hua-Jian Li; Zhu Zhu
Journal:  World J Surg Oncol       Date:  2022-09-19       Impact factor: 3.253

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.